GenMont Biotech Incorporation (TPE:3164)
15.70
-0.05 (-0.32%)
Sep 15, 2026, 1:21 PM CST
| Market Cap | 1.35B -21.0% |
| Revenue (ttm) | 382.11M -1.1% |
| Net Income | 69.17M +344.7% |
| EPS | 0.80 +345.5% |
| Shares Out | 86.01M |
| PE Ratio | 19.60 |
| Forward PE | n/a |
| Dividend | 0.80 (5.06%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 8,545 |
| Open | 15.65 |
| Previous Close | 15.75 |
| Day's Range | 15.65 - 15.75 |
| 52-Week Range | 15.35 - 20.10 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |